跳至主要内容
临床试验/NL-OMON25641
NL-OMON25641招募中不适用

Correlating plasma nintedanib concentrations with clinical outcome and toxicity in patients with interstitial lung disease

Erasmus MC dept. of Medical Oncology and dept. of Pulmonology0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Age 18 years or older;
  • Able to understand the written Information and able to give informed consent;
  • Planned treatment with nintedanib for any fibrotic ILD according to standard of care.

排除标准

  • A potential subject who is unable to draw blood for study purposes will be excluded.

研究者

发起方
Erasmus MC dept. of Medical Oncology and dept. of Pulmonology

相似试验

Correlating plasma nintedanib concentrations with... | 临床试验